Nektar Therapeutics (NKTR) Gross Margin (QoQ) (2010 - 2026)

Nektar Therapeutics (NKTR) Gross Margin (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Nektar Therapeutics 1.51 Bn 939.55 Mn 3.16 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -24,462.00
Dec 31, 2025 17,371.00
Sep 30, 2025 0.00
Jun 30, 2025 16,501.00
Mar 31, 2025 -13,552.00
Dec 31, 2024 -1,111.00
Sep 30, 2024 2,308.00
Jun 30, 2024 1,032.00
Mar 31, 2024 -2,129.00
Dec 31, 2023 2,099.00
Sep 30, 2023 -1,737.00
Jun 30, 2023 -142.00
Mar 31, 2023 -439.00
Dec 31, 2022 -726.00
Sep 30, 2022 265.00
Jun 30, 2022 -228.00
Mar 31, 2022 323.00
Dec 31, 2021 -333.00
Sep 30, 2021 575.00
Jun 30, 2021 -272.00